Isoflurane Induced Malignant Hyperthermia in a Patient with Glucose 6-Phosphate Dehydrogenase Deficiency and Growth Hormone Abuse
Malignant hyperthermia is a pharmacogenetic disorder in the regulation of calcium in skeletal muscles which is related to an uninhibited muscle hypermetabolic reaction to potent inhalation agents, the depolarizing muscle relaxant succinylcholine, and to stressors such as vigorous exercise and heat....
Saved in:
Main Authors: | Hojatolah Ravaei, Mohammad Javad Yavari Barhaghtalab, Vahid Salehi, Hossein Hejr |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Anesthesiology |
Online Access: | http://dx.doi.org/10.1155/2020/8888368 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucose-6-phosphate dehydrogenase deficiency with coinherited Gaucher disease: A rare association
by: Nupur Parakh, et al.
Published: (2024-04-01) -
PUBLIC AWARENESS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE(G6PD) DEFICIENCY CAUSES AND PREVALENCE FACTORS
by: Muath Salman Almuhaini et al
Published: (2024-10-01) -
Case report: Acute Hepatitis E Infection with Co-Existent Glucose-6-Phosphate Dehydrogenase Deficiency
by: Amitabh Monga, et al.
Published: (2003-01-01) -
Effect of High-Dose Vitamin C Infusion in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient
by: Joseph Quinn, et al.
Published: (2017-01-01) -
Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana
by: Patrick Adu, et al.
Published: (2016-01-01)